Atomistic simulation and measurement of pH dependent cancer therapeutic interactions with nanodiamond carrier

Ashfaq Adnan, Robert Lam, Hanning Chen, Jessica Lee, Daniel J. Schaffer, Amanda S. Barnard, George C Schatz, Dean Ho, Wing Kam Liu

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

In this work, we have combined constant-pH molecular dynamics simulations and experiments to provide a quantitative analysis of pH dependent interactions between doxorubicin hydrochloride (DOX) cancer therapeutic and faceted nanodiamond (ND) nanoparticle carriers. Our study suggests that when a mixture of faceted ND and DOX is dissolved in a solvent, the pH of this solvent plays a controlling role in the adsorption of DOX molecules on the ND. We find that the binding of DOX molecules on ND occurs only at high pH and requires at least ∼10% of ND surface area to be fully titrated for binding to occur. As such, this study reveals important mechanistic insight underlying an ND-based pH-controlled therapeutic platform.

Original languageEnglish
Pages (from-to)368-374
Number of pages7
JournalMolecular Pharmaceutics
Volume8
Issue number2
DOIs
Publication statusPublished - Apr 4 2011

Fingerprint

Nanodiamonds
Doxorubicin
Neoplasms
Therapeutics
Molecular Dynamics Simulation
Nanoparticles
Adsorption

Keywords

  • adsorption
  • CpHMD
  • doxorubicine
  • drug delivery
  • nanodiamond

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Molecular Medicine
  • Drug Discovery

Cite this

Adnan, A., Lam, R., Chen, H., Lee, J., Schaffer, D. J., Barnard, A. S., ... Liu, W. K. (2011). Atomistic simulation and measurement of pH dependent cancer therapeutic interactions with nanodiamond carrier. Molecular Pharmaceutics, 8(2), 368-374. https://doi.org/10.1021/mp1002398

Atomistic simulation and measurement of pH dependent cancer therapeutic interactions with nanodiamond carrier. / Adnan, Ashfaq; Lam, Robert; Chen, Hanning; Lee, Jessica; Schaffer, Daniel J.; Barnard, Amanda S.; Schatz, George C; Ho, Dean; Liu, Wing Kam.

In: Molecular Pharmaceutics, Vol. 8, No. 2, 04.04.2011, p. 368-374.

Research output: Contribution to journalArticle

Adnan, A, Lam, R, Chen, H, Lee, J, Schaffer, DJ, Barnard, AS, Schatz, GC, Ho, D & Liu, WK 2011, 'Atomistic simulation and measurement of pH dependent cancer therapeutic interactions with nanodiamond carrier', Molecular Pharmaceutics, vol. 8, no. 2, pp. 368-374. https://doi.org/10.1021/mp1002398
Adnan, Ashfaq ; Lam, Robert ; Chen, Hanning ; Lee, Jessica ; Schaffer, Daniel J. ; Barnard, Amanda S. ; Schatz, George C ; Ho, Dean ; Liu, Wing Kam. / Atomistic simulation and measurement of pH dependent cancer therapeutic interactions with nanodiamond carrier. In: Molecular Pharmaceutics. 2011 ; Vol. 8, No. 2. pp. 368-374.
@article{23512302f46c4a24bdc5b80d9ea575a6,
title = "Atomistic simulation and measurement of pH dependent cancer therapeutic interactions with nanodiamond carrier",
abstract = "In this work, we have combined constant-pH molecular dynamics simulations and experiments to provide a quantitative analysis of pH dependent interactions between doxorubicin hydrochloride (DOX) cancer therapeutic and faceted nanodiamond (ND) nanoparticle carriers. Our study suggests that when a mixture of faceted ND and DOX is dissolved in a solvent, the pH of this solvent plays a controlling role in the adsorption of DOX molecules on the ND. We find that the binding of DOX molecules on ND occurs only at high pH and requires at least ∼10{\%} of ND surface area to be fully titrated for binding to occur. As such, this study reveals important mechanistic insight underlying an ND-based pH-controlled therapeutic platform.",
keywords = "adsorption, CpHMD, doxorubicine, drug delivery, nanodiamond",
author = "Ashfaq Adnan and Robert Lam and Hanning Chen and Jessica Lee and Schaffer, {Daniel J.} and Barnard, {Amanda S.} and Schatz, {George C} and Dean Ho and Liu, {Wing Kam}",
year = "2011",
month = "4",
day = "4",
doi = "10.1021/mp1002398",
language = "English",
volume = "8",
pages = "368--374",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "2",

}

TY - JOUR

T1 - Atomistic simulation and measurement of pH dependent cancer therapeutic interactions with nanodiamond carrier

AU - Adnan, Ashfaq

AU - Lam, Robert

AU - Chen, Hanning

AU - Lee, Jessica

AU - Schaffer, Daniel J.

AU - Barnard, Amanda S.

AU - Schatz, George C

AU - Ho, Dean

AU - Liu, Wing Kam

PY - 2011/4/4

Y1 - 2011/4/4

N2 - In this work, we have combined constant-pH molecular dynamics simulations and experiments to provide a quantitative analysis of pH dependent interactions between doxorubicin hydrochloride (DOX) cancer therapeutic and faceted nanodiamond (ND) nanoparticle carriers. Our study suggests that when a mixture of faceted ND and DOX is dissolved in a solvent, the pH of this solvent plays a controlling role in the adsorption of DOX molecules on the ND. We find that the binding of DOX molecules on ND occurs only at high pH and requires at least ∼10% of ND surface area to be fully titrated for binding to occur. As such, this study reveals important mechanistic insight underlying an ND-based pH-controlled therapeutic platform.

AB - In this work, we have combined constant-pH molecular dynamics simulations and experiments to provide a quantitative analysis of pH dependent interactions between doxorubicin hydrochloride (DOX) cancer therapeutic and faceted nanodiamond (ND) nanoparticle carriers. Our study suggests that when a mixture of faceted ND and DOX is dissolved in a solvent, the pH of this solvent plays a controlling role in the adsorption of DOX molecules on the ND. We find that the binding of DOX molecules on ND occurs only at high pH and requires at least ∼10% of ND surface area to be fully titrated for binding to occur. As such, this study reveals important mechanistic insight underlying an ND-based pH-controlled therapeutic platform.

KW - adsorption

KW - CpHMD

KW - doxorubicine

KW - drug delivery

KW - nanodiamond

UR - http://www.scopus.com/inward/record.url?scp=79953827959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953827959&partnerID=8YFLogxK

U2 - 10.1021/mp1002398

DO - 10.1021/mp1002398

M3 - Article

VL - 8

SP - 368

EP - 374

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 2

ER -